Cargando…

Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients

The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Nupur, Kumar, Krishna, Mallick, Priyanka, Das, Subhrangshu, Kamal, Izaz Monir, Bose, Sarpita, Choudhury, Anindita, Chakrabarti, Saikat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985531/
https://www.ncbi.nlm.nih.gov/pubmed/33767730
http://dx.doi.org/10.3389/fgene.2021.626642
_version_ 1783668267139727360
author Biswas, Nupur
Kumar, Krishna
Mallick, Priyanka
Das, Subhrangshu
Kamal, Izaz Monir
Bose, Sarpita
Choudhury, Anindita
Chakrabarti, Saikat
author_facet Biswas, Nupur
Kumar, Krishna
Mallick, Priyanka
Das, Subhrangshu
Kamal, Izaz Monir
Bose, Sarpita
Choudhury, Anindita
Chakrabarti, Saikat
author_sort Biswas, Nupur
collection PubMed
description The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral–host protein complexes, and in silico drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php.
format Online
Article
Text
id pubmed-7985531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79855312021-03-24 Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients Biswas, Nupur Kumar, Krishna Mallick, Priyanka Das, Subhrangshu Kamal, Izaz Monir Bose, Sarpita Choudhury, Anindita Chakrabarti, Saikat Front Genet Genetics The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral–host protein complexes, and in silico drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php. Frontiers Media S.A. 2021-03-09 /pmc/articles/PMC7985531/ /pubmed/33767730 http://dx.doi.org/10.3389/fgene.2021.626642 Text en Copyright © 2021 Biswas, Kumar, Mallick, Das, Kamal, Bose, Choudhury and Chakrabarti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Biswas, Nupur
Kumar, Krishna
Mallick, Priyanka
Das, Subhrangshu
Kamal, Izaz Monir
Bose, Sarpita
Choudhury, Anindita
Chakrabarti, Saikat
Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title_full Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title_fullStr Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title_full_unstemmed Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title_short Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
title_sort structural and drug screening analysis of the non-structural proteins of severe acute respiratory syndrome coronavirus 2 virus extracted from indian coronavirus disease 2019 patients
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985531/
https://www.ncbi.nlm.nih.gov/pubmed/33767730
http://dx.doi.org/10.3389/fgene.2021.626642
work_keys_str_mv AT biswasnupur structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT kumarkrishna structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT mallickpriyanka structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT dassubhrangshu structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT kamalizazmonir structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT bosesarpita structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT choudhuryanindita structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients
AT chakrabartisaikat structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients